Pfizer CEO says it’s back to basics after painful 2023 for investors

SAN FRANCISCO — Pfizer CEO Albert Bourla said the company has made the major cost-cutting moves required to reset its business, and will focus on executing on operations and growing margins in 2024.

In a wide-ranging lunch with reporters ahead of the company’s presentation at the JP Morgan Healthcare Conference…
Click here to view original post